Massachusetts lawmakers introduced a measure that requires a legal barrier study for first responders to be able to legally use marijuana.
The legislature’s Joint Cannabis Policy Committee on Monday approved the legislation from Sen. Julian Cyr (D), reporting it favorably and sending it to the Senate Ways & Means Committee for further consideration.
In the proposal, it would be required that the Cannabis Control Committee study and report on topics such as drug testing for police officers and first responders; internal policies with regard to cannabis usage for this group of people; the effects of state and federal carry laws and their impact, along with the Controlled Substances Act.
The regulators would need to examine the effectiveness of marijuana for treating anxiety, depression and PTSD. In addition, they would examine other jurisdictions’ laws and police policies regarding cannabis usage by first responders such as officers of the law and police.
According to the bill, “The executive and commission offices may consult experts or hold public hearings and regular public meetings as they consider necessary.”
By December 31, 2026, the commission must submit a final report to both the Legislature and all relevant committees.
This bill was presented as another committee passed a separate piece of legislation that provides employment protections to marijuana users. Another panel advanced a similar employment protections bill from Rep. Michael Kushmerek (D) in September.
In the background of this legislative effort, the Massachusetts attorney general’s office last week confirmed it has been receiving complaints from the public about petitioners for a 2026 ballot initiative aimed at rolling back the state’s marijuana legalization law–with a growing number of people alleging that signature collectors are peddling misleading information about the proposal.
The marijuana repeal campaign, for its part, said last month that they’re “on track” to securing enough signatures to place the initiative on the ballot. By December 3, they must submit at least 100,000 signatures.
Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs.
We will have to wait and see if cannabis measures are approved. The legalization was approved by voters in 2016 and the sales started two years after. In the past decade the cannabis market has evolved and expanded. As of August, Massachusetts officials reported more than $8 billion in adult-use marijuana sales.
—
MEDCAN24 has been tracking the hundreds of bills relating to cannabis, psychedelics or drug policies that have passed through state legislatures as well as Congress in this past year. Patreon members who pledge at least $25/month gain access to interactive maps, charts, and the hearing calendar.
Find out more about our marijuana law tracker. To get access, become a Patreon supporter.
—
Regulators are also working to finalize rules to allow for a new cannabis consumption lounge license type, which they hope to complete by October.
Separately, in May CCC launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry.
State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments.
Also in Massachusetts, legislators who were working on a state budget butted heads with CCC officials, who’ve said they can’t make critical technology improvements without more money from the legislature.
Meanwhile, Massachusetts lawmakers recently approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics. Separately, two committees conducted hearings for the discussion of additional measures related to psilocybin.
MEDCAN24 would not be possible without the support of readers. Consider a Patreon subscription if our marijuana advocacy journalism is what you use to keep informed.
